Few well-known biotech and pharma names escaped what ended up being something of a rout. Amgen (NASDAQ: AMGN) took it on the chin with a more than 2% decline on the day, while Regeneron ...

Michelle Xia gained experience at U.S. pharmaceutical firms before launching her own biotech company back home in China. In a ...

Bloomberg Intelligence’s team of experienced biotech, pharma, policy and litigation analysts author exclusive, data-driven research that can help you pinpoint long-term market opportunities.

The biotechnology sector has experienced a jolt of volatility over the past few days, spearheaded by the dramatic price surges in Tonix Pharmaceuticals (NASDAQ: TNXP) and Lexeo Therapeutics ...

Big pharma's like Pfizer (PFE 1.00%) have partnered with biotech companies to drive growth. I'm thinking of Pfizer's partnership with BioNTech for their blockbuster coronavirus vaccine.

Big Pharma is investing heavily in AI to slash development timelines and foster innovation. But instead of strengthening future relationships with the biotech world, the investment may position ...

While biotech market rout presents pharma companies with cheap targets, don’t count on a handful of deals to turn into critical mass . By . David Wainer. Share. Resize. Listen (2 min) ...

How Trump's presidency will shape the biotech and pharma outlook, according to CEOs of Teva, Bausch + Lomb, GSK, Novo Nordisk, and more.

Here is STAT’s biotech scoreboard, our regular ledger of stock-moving biotech events, for the second quarter and middle of the year: Obesity catalysts, first. Danish drugmaker Zealand Pharma ...

As ever in the often quick-developing biotech and pharmaceutical sectors on Tuesday, companies posted a mix of positive and negative news. Investors clearly took the latter more to heart, as they ...

The biotechnology sector has experienced a jolt of volatility over the past few days, spearheaded by the dramatic price surges in Tonix Pharmaceuticals (NASDAQ: TNXP) and Lexeo Therapeutics ...